[EN] IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17<br/>[FR] IMIDAZOPYRIDAZINES EN TANT QUE MODULATEURS DE L'IL-17
申请人:JANSSEN BIOTECH INC
公开号:WO2021222404A1
公开(公告)日:2021-11-04
The present application discloses compounds having the following formula: (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Improvements in clearance of adenosine series
作者:Suzanne S. Stokes、Madhusudhan Gowravaram、Hoan Huynh、Min Lu、George B. Mullen、Brendan Chen、Robert Albert、Thomas J. O’Shea、Michael T. Rooney、Haiqing Hu、Joseph V. Newman、Scott D. Mills
DOI:10.1016/j.bmcl.2011.11.071
日期:2012.1
Optimization of clearance of adenosine inhibitors of bacterial NAD(+)-dependent DNA ligase is discussed. To reduce Cytochrome P-450-mediated metabolic clearance, many strategies were explored; however, most modifications resulted in compounds with reduced antibacterial activity and/or unchanged total clearance. The alkyl side chains of the 2-cycloalkoxyadenosines were fluorinated, and compounds with moderate antibacterial activity and favorable pharmacokinetic properties in rat and dog were identified. (C) 2011 Elsevier Ltd. All rights reserved.
Monomeric fluorine compounds containing a four-carbon atom ring
申请人:DU PONT
公开号:US02462345A1
公开(公告)日:1949-02-22
Notes - Deamination of 2,2,3,3-Tetrafluorocyclobutanemethylamine